Amino Acid Analysis for Peptides and Proteins: Hydrolysis and Molar Ratios

1. What amino acid analysis can tell you

Amino acid analysis (AAA) measures the free amino acids released when a protein or peptide is hydrolyzed. Calibrating each amino acid allows its amount to be determined. If the molar amount of the original protein or peptide is also known reliably, the result can be expressed as moles of each residue per mole of the protein or peptide.

AAA can check the expected composition and provide an independent quantitative basis for assigning a reference value for protein content. Composition, sequence, and stereochemistry answer different questions. The report should specify which residues the hydrolysis procedure covers and how the denominator was determined.

2. Hydrolysis, derivatization, and separation

Hydrolysis releases amino acid residues. Analytical options include precolumn derivatization, such as fluorescent AQC labeling, followed by reversed-phase liquid chromatography, or ion-exchange chromatography with postcolumn ninhydrin derivatization. The choice depends on the target residues, available instrumentation, and applicable product requirements.

During method development, evaluate residue release and degradation during hydrolysis, the stability of derivative response, chromatographic resolution, and calibration. Better derivatization or separation cannot recover residues lost during hydrolysis.

3. How hydrolysis time affects recovery

Hydrolysis with 6 mol/L hydrochloric acid at 110 °C for 24 hours can be a starting point for conventional acid hydrolysis. Some peptide bonds involving valine or isoleucine cleave slowly, while serine and threonine can degrade as hydrolysis continues. A time course can show when release plateaus for key residues. With sufficient data, extrapolation can help estimate the initial amount of a labile residue.

Conventional hydrochloric acid hydrolysis is unsuitable for direct quantitation of tryptophan. If tryptophan is a target, evaluate alkaline hydrolysis or a suitable acid hydrolysis procedure that protects it. For cysteine and methionine, consider performic acid preoxidation as appropriate for the method objective, then measure cysteic acid and methionine sulfone, respectively. Record the hydrolysis conditions and how recovery was addressed.

4. Choosing a denominator for the result

Absolute quantitation. Use suitable external or internal calibration to determine the molar amount of each residue, then divide by the independently determined molar amount of the protein or peptide. Report the residue-to-molecule molar ratio and document hydrolysis recovery and the basis for any correction.

Normalization to anchor residues. Define a normalization unit from the calibrated amounts and expected residue counts of the selected anchor residues. Express each residue relative to that unit. The ratio depends on how reliably the anchor residues are recovered and quantified.

Peak-area normalization. Response factors and hydrolysis losses differ by residue. An individual peak’s share of the total peak area cannot be interpreted directly as a mole fraction, mass fraction, or residue molar ratio.

5. Composition testing for octreotide acetate

The Octreotide Acetate monograph in Part II of the 2025 Chinese Pharmacopoeia specifies preoxidation followed by acid hydrolysis. One normalization unit is one-third of the combined measured molar amounts of phenylalanine (Phe) and lysine (Lys). Octreotide has two Phe residues and one Lys residue. The monograph uses this unit to calculate relative residue ratios.

Threonine (Thr) at position 6 contributes to the Thr ratio. Position 8 is L-threoninol, a terminal amino alcohol that the monograph checks separately by qualitative detection. Detecting threoninol provides evidence related to this terminus. This check alone cannot establish its position, integrity, or stereochemistry.

6. Validation, pharmacopoeial requirements, and data review

Assess selectivity, accuracy, precision, response, and reportable range against the intended use. Consider hydrolysis time, the interval from derivatization to injection, and sample and derivative stability. Spiking with free amino acids can check the measurement step. Use suitable process controls or reference materials to assess release and recovery during hydrolysis. An orthogonal method of known accuracy can also support the accuracy assessment.

Part IV of the 2025 Chinese Pharmacopoeia includes General Chapter 9120. USP 〈1052〉 identifies its harmonization with corresponding chapters of the European and Japanese pharmacopoeias and marks the non-harmonized passages. Common hydrolysis procedures can serve as development starting points. The applicable product standard, regulatory commitments, and actual procedure determine suitability, use in batch release, and whether method verification, validation, or equivalence work is needed.

Retain calibration curves, blanks, process control and system suitability results, and integration records for review. In the report, document response calibration, quantifiable residues, the basis for peak assignments, how anomalies were handled, and the normalization denominator.

7. How AAA complements peptide mapping, MS, and chiral analysis

Amino acid composition and intact molecular mass can support consistency with the expected residue composition and mass, respectively. Predict theoretical peptides from the known sequence and the cleavage rules used. Determine observed sequence coverage by matching peptides in a peptide map or LC–MS analysis. Conventional achiral AAA generally cannot distinguish D and L enantiomers. Use a suitable chiral method when stereochemistry must be assessed.

For technical discussion. Follow the current applicable pharmacopoeial or approved standard for product tests and limits.

References